About V-Edit
V-Edit is a Healthcare company based in Bengaluru (India) founded in 2024 by Debabrata Jana. It offers genome editing and cell engineering for genetic research and therapeutics. It operates on a B2B model. Its chief executive, as recorded, is Debabrata Jana. Its Indian entity V-Edit Life Sciences Private Limited reported revenue of ₹11.3 Lakh. V-Edit offers products and services including Genome Editing Services and Cell Engineering Services. Its focus areas include Biotechnology, Genome Editing, CRISPR Technology and Cell Engineering.
Company details
V-Edit Life Sciences specializes in genome editing and cell engineering, providing tailored CRISPR-based services for genetic research and biopharma applications. They focus on reliable solutions for cell line development and stem cell therapy, empowering advancements in biotechnology. Located in Bangalore and Bidadi, India, they serve clients in the healthcare sector through collaborative and efficient processes.
- Headquarters Bengaluru, India
- Founders Debabrata Jana
- SectorsHealthcare
- Email••••••••
- Website veditlifesciences.com
- Social LinkedIn
- Legal Name V-Edit Life Sciences Private Limited
- Date of Incorporation 05 Jan, 2024
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹11.3 Lakh
FY 2025 · +2590% YoY
- Net Profit₹1.8 Lakh
FY 2025 · 16% margin
- EBITDA₹2.5 Lakh
FY 2025 · 22% margin
Associated legal entities of V-Edit
V-Edit operates through V-Edit Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| V-Edit Life Sciences Private Limited CIN U21001KA2024PTC183201 | Active | 05 Jan 2024 | Bangalore, Karnataka | ₹0.1 Cr | 3 | View details |
Products & Services of V-Edit
V-Edit offers a comprehensive portfolio of products and services, including Genome Editing Services and Cell Engineering Services.
Provides CRISPR-based genome editing for genetic research applications.
Offers cell line development and engineering for biopharma needs.
Board of directors of V-Edit Life Sciences Private Limited (V-Edit)
V-Edit Life Sciences Private Limited is the primary company behind V-Edit. The board of V-Edit Life Sciences Private Limited currently have 3 directors; the longest-serving is Debabrata Jana, appointed in 2024.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Debabrata Jana DIN 10191670 | Director | 05 Jan 2024 | 2 yrs 10 mo | V-Edit Life Sciences Private Limited |
| Raghavendra Megala DIN 10191671 | Director | 05 Jan 2024 | 2 yrs 10 mo | V-Edit Life Sciences Private Limited |
| Hanuman Tulashiram Kale DIN 11352111 | Additional Director | 23 Oct 2025 | 1 yr | V-Edit Life Sciences Private Limited |
People of V-Edit
1 people are tracked at V-Edit (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder, CEO | Leadership |
Complete people profiles for V-Edit
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of V-Edit
Figures of V-Edit Life Sciences Private Limited, the primary company behind V-Edit, for FY 2025. Revenue was ₹11.3 Lakh (+2590% year on year). Net profit was ₹1.8 Lakh (16% margin). EBITDA was ₹2.5 Lakh (22% margin).
- ₹11.3 LakhRevenue · FY 2025 · +2590% YoY
- ₹1.8 LakhNet profit · 16% margin
- ₹2.5 LakhEBITDA · 22% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of V-Edit Life Sciences Private Limited are on its company page.
Detailed financial statements for V-Edit
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about V-Edit
V-Edit was founded in 2024.
V-Edit is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Debabrata Jana is the CEO of V-Edit, as recorded in our data. They have also founded this company.
The primary company behind V-Edit, V-Edit Life Sciences Private Limited, reported revenue of ₹11.3 Lakh for FY 2025, up 2590% year on year.
V-Edit Life Sciences specializes in genome editing and cell engineering, providing tailored CRISPR-based services for genetic research and biopharma applications. They focus on reliable solutions for cell line development and stem cell therapy, empowering advancements in biotechnology. Located in Bangalore and Bidadi, India, they serve clients in the healthcare sector through collaborative and efficient processes.
V-Edit offers Genome Editing Services and Cell Engineering Services.
V-Edit operates through V-Edit Life Sciences Private Limited.
The legal entities of V-Edit currently have 3 directors, including Debabrata Jana, Raghavendra Megala, Hanuman Tulashiram Kale.